CS299091A3 - 4- or 5-substituted pyridine-2-carboxylic acids, process of their preparation as well as their application as medicaments - Google Patents

4- or 5-substituted pyridine-2-carboxylic acids, process of their preparation as well as their application as medicaments

Info

Publication number
CS299091A3
CS299091A3 CS912990A CS299091A CS299091A3 CS 299091 A3 CS299091 A3 CS 299091A3 CS 912990 A CS912990 A CS 912990A CS 299091 A CS299091 A CS 299091A CS 299091 A3 CS299091 A3 CS 299091A3
Authority
CS
Czechoslovakia
Prior art keywords
medicaments
preparation
well
application
carboxylic acids
Prior art date
Application number
CS912990A
Other languages
Czech (cs)
English (en)
Inventor
Ekkehard Dr Baader
Martin Dr Bickel
Volkmar Dr Gunzler-Pukall
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CS299091A3 publication Critical patent/CS299091A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
CS912990A 1990-10-01 1991-09-30 4- or 5-substituted pyridine-2-carboxylic acids, process of their preparation as well as their application as medicaments CS299091A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4030999A DE4030999A1 (de) 1990-10-01 1990-10-01 4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
CS299091A3 true CS299091A3 (en) 1992-04-15

Family

ID=6415344

Family Applications (1)

Application Number Title Priority Date Filing Date
CS912990A CS299091A3 (en) 1990-10-01 1991-09-30 4- or 5-substituted pyridine-2-carboxylic acids, process of their preparation as well as their application as medicaments

Country Status (19)

Country Link
EP (1) EP0479178A3 (no)
JP (1) JPH072777A (no)
KR (1) KR920008000A (no)
CN (1) CN1060464A (no)
AU (1) AU8485191A (no)
BR (1) BR9104204A (no)
CA (1) CA2052509A1 (no)
CS (1) CS299091A3 (no)
DE (1) DE4030999A1 (no)
FI (1) FI914557A (no)
HU (1) HUT59101A (no)
IE (1) IE913436A1 (no)
IL (1) IL99606A0 (no)
MA (1) MA22312A1 (no)
MX (1) MX9101348A (no)
NO (1) NO913833L (no)
PL (1) PL291880A1 (no)
PT (1) PT99133A (no)
ZA (1) ZA917806B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW199147B (no) * 1991-03-18 1993-02-01 Hoechst Ag
WO2017161555A1 (zh) * 2016-03-25 2017-09-28 沈阳三生制药有限责任公司 用于合成被芳基或杂芳基取代的5-羟基-1,7-萘啶化合物的中间体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432094A1 (de) * 1984-08-31 1986-03-06 Hoechst Ag, 6230 Frankfurt Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase
DE3703963A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen
DE3707429A1 (de) * 1987-03-07 1988-09-15 Hoechst Ag Substituierte pyridin-2,4-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE3924093A1 (de) * 1989-07-20 1991-02-07 Hoechst Ag N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung

Also Published As

Publication number Publication date
CN1060464A (zh) 1992-04-22
MA22312A1 (fr) 1992-07-01
AU8485191A (en) 1992-04-02
PL291880A1 (en) 1992-06-26
KR920008000A (ko) 1992-05-27
HU913120D0 (en) 1992-01-28
EP0479178A3 (en) 1992-10-28
PT99133A (pt) 1992-08-31
JPH072777A (ja) 1995-01-06
MX9101348A (es) 1992-06-05
EP0479178A2 (de) 1992-04-08
FI914557A (fi) 1992-04-02
CA2052509A1 (en) 1992-04-02
BR9104204A (pt) 1992-06-02
IE913436A1 (en) 1992-04-08
NO913833D0 (no) 1991-09-30
IL99606A0 (en) 1992-08-18
ZA917806B (en) 1992-05-27
FI914557A0 (fi) 1991-09-27
HUT59101A (en) 1992-04-28
DE4030999A1 (de) 1992-04-09
NO913833L (no) 1992-04-02

Similar Documents

Publication Publication Date Title
IL83016A (en) Heterocyclic alkylenediamines,process for their preparation and their use as insecticides
HUT59558A (en) New 5-chloro-quinoline-8-oxy-alkane-carboxylic acid derivatives, process for producing and utilizing them as antidotum
EP0119954A3 (en) 3-amino-1-benzazepin-2-one-1-alcanoic acids, process for their preparation, their pharmaceutical preparation as well as their therapeutic use
HUT46000A (en) Process for producing imidazo/4,5-b/pyridine derivatives and pharmaceutics comprising these compounds as active ingredient
CS409591A3 (en) Novel derivatives of bicyclic amino acids, process of their preparation, means comprising said compounds and their application, as well as novel bicyclic amino acids as intermediate products and process for preparing thereof
AR242187A1 (es) Procedimiento para la preparacion de 1-hidroxi-2-piridonas, obtencion de medicamentos que las contienen, e intermediarios utiles en dicho procedimiento.
PL307328A1 (en) Novel derivatives of imidazo [1,2-a] pyridine and method of obtaining them as well as pharmaceutical preparation and method of preparing same
CS299991A3 (en) Derivatives of 2-aminopyrimidine-4-carboxamide, process of their preparation and their application as medicaments
FI981709A0 (fi) Menetelmä 5-substituoitujen 2-amino-4-okso-pyrrolo/2,3-d/-pyrimidiinien valmistamiseksi
HU901428D0 (en) Process for the preparation of 5-substituted 1,4-dihydro-4-oxo-naphthiridine-3-carboxylic acid derivatives
CS299191A3 (en) 4- or 5-substituted pyridine-2-carboxylic acids, process of their preparation as well as their application as medicaments
IL70659A (en) Process for the preparation of 2,3-dihalo pyridines
AU601787B2 (en) Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxy-acetic acids, new intermediate products, processes for their preparation and their use as medicaments
CS235091A3 (en) Novel derivatives of 1-diphenylmethylpiperazine, process of their preparation and their application as medicaments
CS299091A3 (en) 4- or 5-substituted pyridine-2-carboxylic acids, process of their preparation as well as their application as medicaments
AU7726187A (en) 2,3-dihydrofuran derivatives, process for preparing them, and their use as an intermediate for the preparation of tetrahydrofuran derivatives
EP0297496A3 (en) Novel process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives
AU7828287A (en) Method for the preparation of pyridine-2,3-dicarboxylic acids
ZA79271B (en) 1-naphthyl-acetic acid derivatives,process for their preparation and their therapeutic applications
CS390991A3 (en) Thiadiazinone derivatives, process of their preparation andpharmaceuticals based thereon
AU5241690A (en) Process for the preparation of pyridine-2, 3-dicarboxylic acids
AU6947791A (en) Process for the preparation of pyrazolecarboxylic acid derivatives
HUT47109A (en) Process for producing 3-(acylaminomethyl)-5,6,7,8-tetrahydro-imidazo-(1,2-a)pyridine derivatives and pharmaceutical compositions comprising these compounds
IE901504L (en) Derivatives of 4-phenylmethyl-1h-indole, process and¹intermediates of preparation, application as medicaments and¹compositions containing them
DE3560004D1 (en) Substituted salicylamides, process for their production and their use as pharmaceutical preparations